RankAlpha logo
Back to Rankings

GRCE

Grace TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The best post-earnings read-through is that the CRL did not cite clinical deficiencies, while management continues to point to the Phase 3 data package, conference presentations, and strengthened IP estate as support for eventual value recovery if the FDA meeting clarifies a manageable resubmission path [#SEC-8K-2026-06-18].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Despite lower FY2026 R&D spend, GRCE is still a sub-$40 million biotech and could face dilution if the remediation and resubmission cycle takes longer than expected.
Momentum
70
Value
41
Sentiment
67
Setup hits (3d)
— · Net —
AI TargetsBase $2.75 · Bull $6.00 · Bear $0.90
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-26 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net —
Target $6.00
Why
Momentum70 · Δ7d -
Value41 · Δ7d -0.1
Sentiment67 · Δ7d -
So what
Strength-led posture. Favor watchlist adds and disciplined entries.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Sentiment · See AI snapshot
Momentum
70
26% active weight
Current posture
7d trendSoftening
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
67
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade B. Momentum 69.8 / Value 41.1 / Sentiment 67.3

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$40.2M
Beta
0.77
Shares Out
16.27M
P/E (TTM) · Derived
-5.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-4.47
Rev YoY
-100.0%
EPS YoY
-258.4%
Gross Margin
+65.2%
Op Margin
-
Net Debt
-$16.98M
Current Ratio
8.10
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology